2021 Virtual Program

Mon. Sept. 20, 1215-1315
Principles of Infection control – Dr. Susan Poutanen

At the end of the session, participants will be able to:

Target Audience:
CanMeds:

Meet the Speaker:

Mon. Sept. 20, 1315-1335
Ontario Medicine Section Of Lab Med Update 2021 – Dr. Victor Tron

This session with provide a high level update of the activities at Ontario Health – Cancer Care Ontario, concentrating on the updates to cancer biomarkers and genetics.

At the end of the session, participants will be able to:

• Cite the 2020-21 OMA Lab Medicine Sections activities.

CanMeds: Medical Expert (the integrating role), Communicator, Collaborator, Leader, Health Advocate, Professional

Meet the Speaker:
Dr Tron is a Lab Physician with over 30 years of experience in Academic Health Centers. He is currently Medical Lead for Dermatopathology at LifeLabs.

Declaration of Conflict of Interest: None

Mon. Sept. 20, 1335-1345
Ontario Health – Cancer Care Ontario Update – Dr. Aaron Pollett

This session with provide a high level update of the activities at Ontario Health – Cancer Care Ontario, concentrating on the updates to cancer biomarkers and genetics.

At the end of the session, participants will be able to:

• Describe the updates that have happened with Ontario Health over 2021
• Plan for biomarker changes through 2022 / 2023
• Describe the updates in genetics with Ontario Health

Target Audience: Faculty, Residents
CanMeds: Communicator, Leader, Health Advocate

Meet the Speaker:
Dr. Aaron Pollett is the Provincial Head, Pathology and Laboratory Medicine Program at Ontario Health – Cancer Care Ontario (OH-CCO). He is an Anatomic Pathologist and Co-Director of the Division of Diagnostic Medical Genetics at Mount Sinai Hospital and an associate professor in the department of Laboratory Medicine and Pathobiology at the University of Toronto. Dr. Pollett has a specialty interest in gastrointestinal pathology and pathology informatics with a Master’s Degree from the Department of Health Policy, Management and Evaluation, University of Toronto. He is the review pathologist for the Familial Gastrointestinal Cancer Registry (FGICR) and the Ontario Familial Colon Cancer Registry (OFCCR), tumour based registries constructed to analyze the genetic basis of gastrointestinal cancers. In his various roles, Dr. Pollett oversees the molecular analysis of solid cancers as well as the development and implementation of new molecular biomarkers.

Declaration of Conflict of Interest: None

Mon. Sept. 20, 1345-1410
Forensic Pathology Update – Dr. Michael Pollanen

Update of Forensic section activities.

At the end of the session, participants will be able to:

• Review the pathology and autopsy precautions of COVID-19.
• Demonstrate recent trends in autopsy practice in Ontario.
• Review current key performance indicators for medicolegal autopsies in Ontario.

Target Audience: Faculty, Residents
CanMeds: Communicator, Leader, Health Advocate

Meet the Speaker:
Chief Forensic Pathologist for Ontario, Canada and a Professor and Vice-Chair (Innovation) of Laboratory Medicine and Pathobiology at the University of Toronto. His duties include supervising and directing the Ontario Forensic Pathology Service (7000 autopsy/year) conducting autopsy (>2500 autopsies conducted to date, testifying in court (>250 court testimonies to date) and directing academic activities in forensic pathology at the University of Toronto. Professor Pollanen’s main educational focus is training forensic pathologists and strengthening forensic capacity in the Global South. His current research interest is Nodding Syndrome in Uganda. He has published over 100 papers in peer-reviewed journals. Professor Pollanen is a member of the forensic advisory board of the International Committee of the Red Cross and is a Past President of the International Association of Forensic Science. He is a Founder of Forensic Pathology in the Royal College of Physicians and Surgeons of Canada.

Declaration of Conflict of Interest: None

Mon. Sept. 20, 1410-1430
Standards 2 Qualify – Version 3 – Dr. Katherine Chorneyko

Standards2Quality (S2Q) is a document originally developed in 2011 as a collaborative
initiative of the Ontario Association of Pathologists and the OMA Section of Laboratory Medicine. Version 2 was released in 2013 but it has not been updated since. This presentation will summarize the work done over the past year by the S2Q working group to update the document, reflecting changes in quality and patient safety which have evolved since 2013.

At the end of the session, participants will be able to:

• Identify the key components of a quality management program for pathology professional practice.

Target Audience: Faculty, Residents, Medical Students
CanMeds: Communicator, Leader, Health Advocate, Professional

Meet the Speaker:
Dr. K. Chorneyko is a pathologist and medical laboratory director at Brant Community Healthcare System and West Haldimand General Hospital. Trained in anatomical and general pathologist, she has worked in both academic and community laboratory environments. She is past president of the Ontario Association of Pathologists (OAP). She has been involved with Path2Quality for many years contributing to both the Standards2Quality and Work2Quality documents.

Declaration of Conflict of Interest: None

Mon. Sept. 20, 1430-1515
Transfusion Medicine Guidelines – Dr. Akash Gupta

This session will review the current indications
for red blood cell and platelet transfusion and highlight the benefits of prospective order screening.

At the end of the session, participants will be able to:

• Summarize the landmark transfusion trials
• Evaluate the appropriateness of blood product orders at their institute
• Identify gaps in the current transfusion medicine literature

Target Audience: Faculty, Residents, Medical Students, MLTs
CanMeds: Medical Expert (the integrating role), Collaborator, Health Advocate

Meet the Speaker:
Dr. Akash Gupta is a Transfusion Medicine Specialist at Sunnybrook Health Sciences Centre and a Medical Officer with Canadian Blood Services overseeing the platelet immunology lab. Akash completed his residency training in General Pathology at McMaster University and fellowship training in Transfusion Medicine at McMaster University and Canadian Blood Services.

Declaration of Conflict of Interest: None

Tue. Sept. 21, 1200-1300
Molecular testing in the evaluation of undifferentiated neoplasms – Dr. Brendan Dickson

This presentation will highlight the role of molecular testing in the classification of undifferentiated neoplasms. This will include the application of targeted RNA and DNA sequencing, as well as molecular cytogenetics.

At the end of the session, participants will be able to:

• identify situations in which NGS can be applied, as a diagnostic adjunct, in tumour classification
• recognize the main advantages, and disadvantages, of RNA-sequencing in fusion gene detection

Target Audience: Faculty, Residents
CanMeds: Medical Expert (the integrating role), Communicator, Collaborator, Leader, Health Advocate, Scholar, Professional

Meet the Speaker:
Dr. Dickson obtained an MSc in Experimental Pathology from Dalhousie University, followed by medical school and residency training at the University of Toronto. He then undertook a clinical fellowship in Bone and Soft Tissue Pathology at Pennsylvania Hospital – University of Pennsylvania, before returning to Toronto where he is currently a Pathologist in the Department of Pathology and Laboratory Medicine at Mount Sinai Hospital, and Associate Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. His research is centred on elucidating the mechanisms of sarcomagenesis, and improving the diagnosis and classification of bone and soft tissue neoplasms. In addition to a busy clinical practice, he is actively engaged in pathology education locally and internationally.

Declaration of Conflict of Interest: None

Tue. Sept. 21, 1300-1430
Potpourri of interesting cases – Dr. Nancy Liu, Dr. Andrea Grin, Dr. Corwyn Rowsell, Dr. Bret Wehrli

Multiple pathologists will take turns presenting the clinical, histological, and ancillary tests used to confirm the diagnosis, of rare, unusual, challenging or interesting cases that they have encountered in their practice.

At the end of the session, participants will be able to:

• Recognize and report important histological entities with an appropriate differential diagnosis
• Order appropriate ancillary testing to confirm a diagnosis and exclude entities in the differential diagnosis
• Discuss the importance of clinical pathological correlation in helping to confirm the diagnosis of these entities

Target Audience: Faculty, Residents, Medical Students
CanMeds: Medical Expert (the integrating role), Communicator

Meet the Speakers:
Dr. Liu is a staff pathologist at Halton Healthcare, Oakville, and an assistant clinical professor in the Department of Pathology and Molecular Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario. Dr. Liu obtained her medical degree and Master’s degree from Zhejiang University. She then underwent residency training in both pathology and internal medicine, as well as post-doctoral fellowships in basic science research and subspecialty pathology in Canada and the US.
She is interested in basic, clinical, and translational research to investigate mechanisms that regulate liver and other organ disorders. She has published more than 40 papers and book chapters. In addition to her research, Dr. Liu is a passionate educator. She teaches medical students, pathology residents, and at international liver pathology workshops and conferences

Declaration of Conflict of Interest: None

Dr. Andrea Grin is Head of Anatomical Pathology at Kingston Health Sciences Centre and Assistant Professor in the Department of Pathology and Molecular Medicine at Queen’s University. She obtained her medical degree and completed residency training in anatomical pathology at the University of Toronto, followed by a surgical pathology fellowship with a focus in gastrointestinal pathology at St. Michael’s Hospital in Toronto. Dr. Grin has over 25 peer-reviewed publications to date and has an interest in education and quality assurance.

Declaration of Conflict of Interest: None

Dr. Corwyn Rowsell is Division Head of Pathology at Unity Health Toronto and Associate Professor in the Department of Laboratory Medicine at University of Toronto. His main clinical interest is gastrointestinal and hepatobiliary pathology. Academic interests include undergraduate medical education, quality assurance, and application of artificial intelligence to pathology.

Declaration of Conflict of Interest: None

Dr. Wehrli graduated from the University of Toronto Medical School in 1995 and undertook residency training in Anatomical Pathology at the University of British Columbia, in Vancouver. After completing a one-year Fellowship in General Surgical Oncological Pathology at the M.D. Anderson Cancer Centre in Houston, Texas (2001) he accepted a faculty position in the Department of Pathology at the London Health Sciences Centre and Schulich School of Medicine at Western University, London, Ontario, where he has been since 2001. An associate professor, Dr. Wehrli is the Team Leader for Bone and Soft Tissue Pathology and Head and Neck Pathology, and he has been the Director of the Immunohistochemistry Lab at LHSC since 2005 which currently performs 55,000+ IHC tests per year. Dr. Wehrli is also an assessor for the Ontario Institute of Quality Management in Healthcare Proficiency Testing Program in Immunohistochemistry.

Declaration of Conflict of Interest: None

Tue. Sept. 21, 1430 – 1530
Who Updates In Gynecologic Tumours: Review Of Recommendations And Practical Tips For Classification – Dr. Emily Goebel

This session provides an overview of some of the updates outlined in the 2020 WHO Classification of Female Genital Tumours, specifically focusing on vulvar neoplasia, endometrial carcinomas, and uterine mesenchymal tumours.

At the end of the session, participants will be able to:

• Explain the changes in classification of vulvar neoplasia and endometrial carcinomas
• Identify recently described and emerging uterine mesenchymal tumours
• Discuss the implications of accurate tumour characterization for patient management

Target Audience: Faculty, Residents, Medical Students
CanMeds: Medical Expert (the integrating role), Communicator, Health Advocate, Scholar, Professional

Meet the Speaker:
Dr. Emily Goebel completed medical school at the University of Toronto and residency training in Anatomical Pathology at Western University. She then completed fellowships in Women’s and Perinatal Pathology at Brigham and Women’s Hospital in Boston and Breast Pathology at Toronto General Hospital. She is currently a practicing pathologist at London Health Sciences Centre and Assistant Professor in the Department of Pathology and Laboratory Medicine at Western University. Dr. Goebel is currently the elected member-at-large of the CAP-ACP Gynecologic Pathology Specialty Interest Group. Her research interests include molecular alterations in gynecologic tumours and their impact on diagnosis and treatment as well as competency based medical education.

Declaration of Conflict of Interest: None

Wed. Sept. 22, 1200-1330
The most common spindle cell tumors of deep soft tissue: differential diagnosis and best markers – Dr. Jason Hornick

Spindle cell tumors of deep soft tissue include relatively common benign, intermediate, and malignant neoplasms, which can be difficult to distinguish from one another. In recent years, novel markers have been developed that have made it easier to reach a specific diagnosis. This session will discuss the differential diagnosis of common spindle cell tumors of deep soft tissue and explain the application of novel diagnostic markers.

At the end of the session, participants will be able to:

Target Audience: Pathologists, Residents, Fellows
CanMeds: Medical Expert (the integrating role)

Meet the Speaker:
Dr. Hornick is the Director of Surgical Pathology and Immunohistochemistry at Brigham and Women’s Hospital and Professor of Pathology at Harvard Medical School. He is the Editor of the 5th series of the AFIP fascicles. Dr. Hornick chaired the USCAP Education Committee and the CAP Immunohistochemistry Committee and is on the USCAP Board of Directors. He was a member of the editorial board for the 4th and 5th editions of the WHO Classification of Soft Tissue and Bone Tumors.
Dr. Hornick serves on 13 editorial boards, including the American Journal of Surgical Pathology and Modern Pathology. He is an Associate Editor for Sternberg’s Diagnostic Surgical Pathology, a Regional Editor for Histopathology, an Associate Editor for Advances in Anatomic Pathology, and the Consulting Editor for Surgical Pathology Clinics. Dr. Hornick has published around 500 original papers, reviews, and chapters and edits the textbook Practical Soft Tissue Pathology: A Diagnostic Approach.

Declaration of Conflict of Interest: Dr. Jason Hornick receives direct financial support as a consultant from Aadi Biosciences; TRACON Pharmaceuticals

Wed. Sept. 22, 1345-1515
Metastatic carcinoma of unknown primary: diagnostic approach using immunohistochemistry – Dr. Jason Hornick

(1) Spindle cell tumors of deep soft tissue include relatively common benign, intermediate, and malignant neoplasms, which can be difficult to distinguish from one another. In recent years, novel markers have been developed that have made it easier to reach a specific diagnosis. This session will discuss the differential diagnosis of common spindle cell tumors of deep soft tissue and explain the application of novel diagnostic markers.
(2) Metastatic carcinomas of unknown (or uncertain) primary are commonly encountered by surgical pathologists. A wide (sometimes overwhelming) array of diagnostic markers for immunohistochemistry are available. This session will discuss a practical approach to the differential diagnosis of metastatic carcinoma of unknown primary, focusing on epidemiology, histology, and immunohistochemistry.

At the end of the session, participants will be able to:

1. Distinguish Among The Most Common Spindle Cell Tumors Of Soft Tissue
2. Apply Novel Immunohistochemical Markers For The Differential Diagnosis Of Spindle Cell Soft Tissue Tumors
3. Apply Immunohistochemistry In The Approach To Metastatic Carcinomas Of Unknown Primary

Target Audience: Pathologists, Residents, Fellows
CanMeds: Medical Expert (the integrating role)

Wed. Sept. 22, 1515 -1615
Career in academic medicine – Dr. Jason Hornick

At the end of the session, participants will be able to:

Target Audience:
CanMeds: